NCT04000529 2025-09-30Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesNovartisPhase 1 Terminated122 enrolled
NCT02429089 2020-01-09CETLEE011Cliniques universitaires Saint-Luc- Université Catholique de LouvainPhase 1 Terminated21 enrolled
NCT03179956 2019-02-25Impact of Ribociclib on Head and Neck Squamous Cell CancerFox Chase Cancer CenterPhase EARLY_PHASE1 Terminated1 enrolled